December 2010 Issue
Clearing the Waters on GE Salmon
The topic of genetically engineered (GE) salmon is making headlines. The Food and Drug Administration (FDA) held hearings in September 2010 to evaluate an application for the sale of AquAdvantage Salmon, a GE salmon with a growth hormone gene that allows it to reach market size twice as fast as conventional salmon. The FDA has not made a final decision on whether it can be sold. It will first publish an Environmental Assessment on the salmon, allow a 30-day comment period, and decide if there are environmental impacts to consider.
To continue reading this entire article you must be a paid subscriber.
Subscribe to Environmental Nutrition
Get the next year of Environmental Nutrition for just $20. And access all of our online content - how to fight heart disease, cancer, stroke, diabetes, osteoporosis, Alzheimer's, and dozens of other diseases - free of charge.
Already subscribe but haven't registered for all the benefits of the website? Click here.
Subscriber Log In
Forgot your password? Click Here.